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Abstract: AIMS Treatment of patients with systemic cardiac implantable electronic device (CIED) infec-
tion with large lead vegetations is challenging and associated with relevant morbidity and mortality. To
avoid complications from open surgical extraction, a novel approach with percutaneous aspiration of large
vegetations prior to transvenous lead extraction was instituted. The results of this treatment concept were
retrospectively analysed in this multicentre study. METHODS AND RESULTS One hundred and one
patients [mean age 68.2 ± 13.1 (30-92) years] were treated in four centres for endovascular CIED infection
with large lead vegetations. Mean lead vegetation size was 30.7 ± 13.5 mm. Two hundred and forty-seven
leads were targeted for extraction (170 pacemaker leads, 77 implantable cardioverter-defibrillator leads).
Mean lead implant duration was 81.7 (1-254) months. The transcatheter aspiration system with a spe-
cialized long venous drainage cannula and a funnel-shaped tip was based on a veno-venous extracorporeal
circuit with an in-line filter. The aspiration of vegetations showed complete procedural success in 94.0%
(n = 95), partial success in 5.0% (n = 5). Three major complications (3.0%) were encountered. Complete
procedural success (per lead) of the subsequently performed transvenous lead extraction procedure was
99.2% (n = 245). Thirty-day mortality was 3.0% (n = 3). Five patients (5.0%) died in the further
course on Days 51, 54, 68, 134, and 182 post-procedure (septic complications: n = 4; heart failure: n =
1). CONCLUSION The percutaneous aspiration procedure is highly effective and is associated with a
low complication profile. The aspiration of vegetations immediately prior and during the lead extraction
procedure may avoid septic embolization into the pulmonary circulation. This may potentially lead to a
long-term survival benefit.
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Aims Treatment of patients with systemic cardiac implantable electronic device (CIED) infection with large lead vegeta-
tions is challenging and associated with relevant morbidity and mortality. To avoid complications from open
surgical extraction, a novel approach with percutaneous aspiration of large vegetations prior to transvenous lead





One hundred and one patients [mean age 68.2 ± 13.1 (30–92) years] were treated in four centres for endovascular
CIED infection with large lead vegetations. Mean lead vegetation size was 30.7 ± 13.5mm. Two hundred and forty-
seven leads were targeted for extraction (170 pacemaker leads, 77 implantable cardioverter-defibrillator leads).
Mean lead implant duration was 81.7 (1–254) months. The transcatheter aspiration system with a specialized long
venous drainage cannula and a funnel-shaped tip was based on a veno-venous extracorporeal circuit with an in-line
filter. The aspiration of vegetations showed complete procedural success in 94.0% (n=95), partial success in 5.0%
(n=5). Three major complications (3.0%) were encountered. Complete procedural success (per lead) of the sub-
sequently performed transvenous lead extraction procedure was 99.2% (n=245). Thirty-day mortality was 3.0%
(n=3). Five patients (5.0%) died in the further course on Days 51, 54, 68, 134, and 182 post-procedure (septic
complications: n=4; heart failure: n=1).
...................................................................................................................................................................................................
Conclusion The percutaneous aspiration procedure is highly effective and is associated with a low complication profile. The as-
piration of vegetations immediately prior and during the lead extraction procedure may avoid septic embolization
into the pulmonary circulation. This may potentially lead to a long-term survival benefit.
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Optimal treatment of endovascular infections of cardiac implantable
electronic devices (CIEDs) remains a challenge, especially in the set-
ting of large lead vegetations. Lead vegetation size of >20mm in di-
ameter is a cut-off parameter to discuss open surgical extraction as
opposed to transvenous lead extraction.1 The 2015 ESC/EACTS
guidelines on infective endocarditis refer to surgical extraction in the
setting of large lead vegetations (>20mm) as a Class IIb indication.2
Open surgical extraction in such situations carries a relevant risk of
morbidity and mortality.3On the other hand, there exist case reports
and case series, that report successful transvenous extraction proce-
dures in large lead vegetations with low perioperative mortality.4,5 In
this context, it remains unclear why endovascular CIED infection car-
ries a 1-year mortality rate of up to 30% despite state of the art treat-
ment (complete CIED explantation and antibiotic therapy).6 To
avoid open extraction, a novel approach with percutaneous aspira-
tion of large vegetations (defined as >_20mm) prior to and during
transvenous lead extraction procedures was introduced.
Methods
Indication for percutaneous aspiration
procedure
The indications for the described concomitant aspiration procedure in
patients undergoing transvenous lead extraction procedures were de-
fined as follows:
• Patients with systemic CIED infection with lead vegetations and a veg-
etation size of equal to or more than 20mm in the longest axis mea-
sured by transoesophageal echocardiography (TOE).
• Patients with smaller vegetation size (10–20mm) and persistent fora-
men ovale.
Transcatheter aspiration procedure using an
extracorporeal circuit
The transcatheter aspiration system is based on an extracorporeal circuit
used in a veno-venous configuration similar to an extracorporeal mem-
brane oxygenation circuit, except it uses a filter system instead of an oxy-
genator (Figure 1). Venous access was achieved by cannulating both
femoral veins. Before placement of the cannulas, heparin was adminis-
tered intravenously with a target activated clotting time of >250 s. The
right femoral vein was used to place a 26-Fr Gore DrySeal Sheath (Gore
Medical, USA) percutaneously as access for the AngioVac drainage can-
nula (Angiodynamics, USA). The AngioVac cannula is a 22-Fr coil-
reinforced cannula with a length of 90 cm, an expandable funnel shaped
distal tip and a 20-angulation of the tip. The expanded funnel-shaped tip
improves venous drainage and the aspiration of vegetation material
(Figure 2). To return the filtered blood, an 18-Fr FemFlex II cannula
(Edwards Life Sciences, USA) was placed percutaneously via the left fem-
oral vein. The aspiration procedure was guided by TOE and fluoroscopy,
which allows for immediate monitoring of procedural success and poten-
tial intraprocedural complications.
One of the limitations of the current AngioVac cannula is its limited
steerability. To overcome this issue in cases where more steerability was
required, an Amplatz Gooseneck Snare, introduced via a second venous
sheath in the left femoral vein, was used to grab the tip of the cannula and
create a wider range of motion by a corresponding push-and-pull
technique.
The aspiration was started prior to the extraction and ideally the lead
vegetations were removed completely before the extraction procedure
was started. It was common that residual vegetation material could not
be removed with the Angiovac system prior to the extraction procedure
due to tight adherence to the leads. Therefore, the aspiration was contin-
ued during the extraction procedure in all cases to eliminate all residual
vegetative material, which was mobilized during the extraction proce-
dure. In cases with very strong adherence of the vegetation to the lead,
the aspiration was facilitated by the mobilization of the vegetation with
the extraction sheath.
Definitions of success of the aspiration
procedure
Complete procedural success of the transcatheter aspiration procedure
was defined as complete removal of all vegetative material determined by
TOE.
Partial success of the aspiration procedure was defined by removal of
most vegetative material with a maximum portion of 30% or less of
remaining vegetation.
Failure was defined any procedure which left more than 30% of vegeta-
tion in situ.
All patients were continuously monitored by TOE during the entire
procedure to evaluate the success of the aspiration using the above de-
scribed definitions and to rule out partial or complete pulmonary emboli-
zation of vegetations, while recognizing the limitations of TOE with
regard to this aspect.
Transvenous lead extraction procedure
The subclavian approach was primarily chosen for lead extraction proce-
dures. For leads that could not be extracted by simple traction, a multi-
step staged lead extraction approach was performed. Application of trac-
tion was performed with the help of a locking stylet (Liberator, Cook
Medical, USA). Additional lead control was achieved by the application of
a compression coil (One-Tie, Cook Medical, USA). In case of severe fi-
brotic or calcified adhesions at the site of the vessel entry below the clavi-
cle, the Evolution Shortie RL (Cook Medical, USA) was used. To apply
counterpressure or countertraction along the course of a targeted lead
either a simple polypropylene extraction sheath (Byrd Dilator Sheath,
Cook Medical, USA) or a rotational mechanical dilator sheath (Evolution
RL, Cook Medical, USA) were used in most cases. In a small number of
leads (n=14), a laser sheath (SLS II, Spectranetics, USA) was used. In case
of failed or impossible superior approach, a femoral approach using a
snare (Needle’s Eye Snare, CookMedical, USA) was performed.
All procedures were performed in a hybrid operating room under gen-
eral anaesthesia by a cardiac surgeon (n=100) or a cardiologist (n=1)
with standby extracorporeal circulation and a perfusionist. Patients were
monitored by electrocardiogram, invasive blood pressure measurement,
pulse oximetry, and TOE.
What’s new?
• A novel, minimally-invasive approach to treat patients with car-
diac implantable electronic device infections with large lead
vegetations is described.
• The percutaneous aspiration procedure of lead vegetations,
which is performed concomitant to the required transvenous
lead extraction, proved to be safe and effective.





































































Success was defined either as clinical success or as complete proce-
dural success according to the definitions of the 2017 Heart Rhythm
Society expert consensus.7
Statistics
Categorical variables are presented as numbers and percentages.
Continuous variables are presented as mean ± standard deviation or as
mean and range from minimum to maximum. Differences between
groups were analysed by two sample t-test. A P-value of <0.05 was con-
sidered significant.
The local review boards approved the research protocol. The results
obtained were analysed retrospectively with regard to efficacy and safety.
Results
Patient population
From July 2014 until November 2018, 101 patients [mean age 68.2 ±
13.1 (30–92) years; 71 male, 30 female] were treated for endovascu-
lar CIED infection with large lead vegetations at four high-volume
lead extraction centres (German Heart Center Berlin, Germany;
Providence Saint Joseph Medical Center, Burbank, CA, USA; Smidt
Heart Institute, Cedars Sinai Medical Center, Los Angeles, CA, USA;
and University Hospital Zurich, Zurich, Switzerland). Mean lead vege-
tation size determined in preoperative echocardiography was 30.7 ±
13.5mm. The distribution of vegetations sizes were as follows: vege-
tation <20mm: n=16 (15.8%); >_20mm and <25mm: n=19
(18.8%); >_25mm and <_30mm: n=24 (23.8%); >30mm: n=42
(41.6%). The minimum size of lead vegetation included was 15mm.
Most lead vegetations were found to be adhering to the lead course
in the right atrium. Less frequently vegetations were found to be in
Figure 1 Percutaneous vegetation aspiration using the AngioVac system (Angiodynamics, Latham, NY, USA) relies on an extracorporeal circuit
used in a veno-venous configuration incorporating a filter/bubble trap system (Photo courtesy: Angiodynamics, Latham, NY, USA).
Figure 2 The AngioVac cannula (Angiodynamics, USA) is a 22-Fr
coil-reinforced cannula (length 90 cm) with an expandable funnel
shaped distal tip. The expanded funnel-shaped tip improves venous
drainage and the aspiration of vegetation material (Photo courtesy:
Angiodynamics, Latham, NY, USA).





































































the superior vena cava (SVC) or in the right ventricle. In seldom
cases, there was concomitant involvement of the tricuspid valve.
Blood cultures were positive in 94 patients (93.1%) [Staphylococci
in 56 patients (55.4%)]. Blood cultures were negative in 7 patients
(6.9%).
In these 101 patients 247 leads were targeted for extraction [170
pacemaker leads, 77 implantable cardioverter-defibrillator (ICD)
leads]. Mean lead implant duration was 81.7 (1–254) months. Table 1
provides the patient and lead characteristics.
Procedural outcomes-aspiration
procedure
The veno-venous configuration of the extracorporeal circuit to facili-
tate the percutaneous aspiration procedure was achieved by
femoro-femoral cannulation in 98 patients. In three patients, the aspi-
ration cannula was placed via the right internal jugular vein and the re-
turn cannula in the left femoral vein. The average perfusion time of
the extracorporeal circuit was 30.2± 18.3min.
The aspiration of the vegetations (Figure 3) showed complete pro-
cedural success in 94.0% (n=95) of all cases. In one case, a highly mo-
bile vegetation embolized into the pulmonary circulation prior to
aspiration. This embolus did not result in any haemodynamic conse-
quences and the subsequent transvenous lead extraction procedure
was carried out successfully.
Three major complications related to the aspiration procedure
were encountered. In one case, the right iliac vein was perforated
and needed subsequent repair with a covered stent. The patient re-
covered uneventfully. In the second case, a patient with systemic
CIED infection with large lead vegetations died intraoperatively due
to refractory septic shock prior to completion of the procedure.
Cannula placement was uneventful and the extracorporeal circuit of
the AngioVac system worked correctly. Pericardial tamponade was
ruled out in TOE. Due to severe septic shock with haemodynamic
compromise despite maximal dose of vasopressors, it was regarded
as highly unlikely that this event was related to the aspiration proce-
dure, but it cannot be completely ruled out, that the aspiration pro-
cedure did not affect the outcome at all. In the third case, a patient
had haemodynamic collapse shortly after initiation of the aspiration
procedure and needed intraoperative resuscitation with return of
spontaneous circulation in less than 2 min. The procedure was suc-
cessfully completed and patient recovered uneventful without any
neurologic deficiencies post-operatively. The patient was discharged
on post-operative Day 2.
Procedural outcomes-concomitant
transvenous lead extraction procedure
Complete procedural success (per targeted lead) of the subsequently
performed transvenous lead extraction procedure was 99.2%
(n=245). A locking stylet (Liberator, Cook Medical, USA) was used
in 64.0% (n=158) and a polypropylene extraction sheath (Byrd
Sheath, Cook Medical, USA) in 1.2% (n=3) of all targeted leads.
A mechanical rotational extraction sheath was required for the ex-
traction of 56.7% (n=140) of the leads, with the Evolution RL (Cook
Medical, USA) in 139 leads and the Tightrail (Spectranetics, USA) in
one lead. Fourteen leads (5.7%) were extracted with the use of a la-
ser sheath (SLS II, Spectranetics, USA). Two major complications re-
lated to the transvenous lead extraction procedure occurred (n=2;
2.0%) In both cases, severe tricuspid regurgitation resulted after the
extraction of dual coil ICD leads with long lead implant durations.
One patient was treated conservatively and the other patient re-
ceived a biological tricuspid valve replacement. Both patients recov-
ered well from the procedure.
Thirty-day mortality was 3.0% (n=3). Further follow-up was in-
complete, but the mortality that became aware to the study sites,
was recorded as follows: 5 patients (5.0%) died on post-operative
Days 51, 54, 68, 134, and 182 (septic complications: n=4; heart fail-
ure: n=1). Due to the lack of follow-up data beyond 30 days post-
operatively, data are not sufficient to calculate or display mid- or
long-term survival. Table 2 gives an overview of the results.
Discussion
Cardiac implantable electronic device infections are a relevant clinical
problem with a disproportional increase in relation to the rising
Table 1 Baseline characteristics
Number of patients 101




Diabetes mellitus 29 (28.7%)
Chronic kidney disease 41 (40.6%)
Bacteria
Methicillin-sensible Staphylococcus aureus 22 (21.7%)
Methicillin-resistant Staphylococcus aureus 9 (8.9%)
Staphylococcus epidermidis 25 (24.8%)
Other Staphylococcus 12 (11.9%)
Enterococcus faecium 4 (4.0%)
Escherichia coli 1 (1.0%)
Streptococcus 9 (8.9%)
Other bacteria 12 (11.9%)
Culture negative 7 (6.9%)
Number of targeted leads 247
Mean lead implant duration (months) 81.7 (1–254)
Number of targeted leads per patient 2.4 ± 1.2
Lead characteristics
Pacemaker leads 170 (68.8%)
ICD leads (single vs. dual coil) 77 (31.2%)
(28 vs. 49)
Active fixation 180 (72.9%)
Passive fixation 67 (27.1%)
Right atrial leads 80 (32.4%)
Right ventricular leads 132 (53.4%)
Left ventricular leads 35 (14.2%)
Mean lead vegetation size (mm) (preoperative TOE) 30.7 ± 13.5
This provides the patient and lead characteristic.
ICD, implantable cardioverter-defibrillator; TOE, transoesophageal
echocardiography.





































































numbers of CIED implantations.8 The main principle of treating such
infections is the complete removal of the device system, which repre-
sents a Class I indication for lead extraction.7,9
According to the 2015 ESC guidelines for the management of in-
fective endocarditis, cardiac device-related infective endocarditis is a
Class I indication for percutaneous extraction even in the presence
of vegetations >10mm. According to these guidelines, surgical ex-
traction may be considered in patients with large vegetations
(>20mm), however, this is merely a Class IIb indication.2
Grammes et al.10 reported the results of a single-centre experi-
ence in percutaneous lead extraction in 100 patients with intracardiac
vegetations. Mean vegetation diameter was reported to be 1.6 cm,
ranging from 0.2 to 4.0 cm. They reported no intraoperative mortal-
ity, but a 30-day mortality of 10% in this patient cohort. There exist
several case reports and series reporting successful transvenous lead
extraction procedures in patients with large lead vegetations.4,5
Open surgical extraction in case of large lead vegetations becomes
uncommon and has become a bail-out option nowadays. There is
data showing that open surgical extraction carries a higher mortality
at 1 and 12months than percutaneous extraction procedures. The
study reporting these mortality differences also showed that patients
undergoing surgical extraction had a higher comorbidity index and
larger vegetations, suggesting a selection bias in the reported results.3
There is enough evidence showing that endovascular infection of
CIED systems carries a relevant long-termmortality, even though the
patients were treated according to current recommendations with
complete system explantation and antibiotic therapy. In the published
results of the ELECTRa registry, systemic infection was identified as a
predictor for increased all-cause mortality (odds ratio 4.93, 95% con-
fidence interval 2.72–8.93; P<0.0001).11 Tarakji et al.6 reported a 1-
year mortality rate of 20% in patients with endovascular infection in
an overall patient cohort of 502 patients with CIED infection (endo-
vascular and pocket infection). Compared to the patients with pocket
infections the mortality rate in the patients with endovascular
infection was significantly higher (hazard ratio 2.1; P=0.0008).
However, the authors could not find a correlation between patient
mortality and the presence of vegetations in the patient group with
endovascular infection.6Greenspon et al.12 showed in a group of 129
patients with lead associated endocarditis that 6-month mortality sig-
nificantly increased as a function of vegetation size. Six-month mortal-
ity in patients with lead vegetations smaller than 1.0 cm was 10.1% vs.
18.4% in patients with a vegetation size of more than 1.0 cm.
Percutaneous lead extraction in patients with lead vegetations
without prior aspiration of the vegetations may lead to septic emboli
into the pulmonary circulation. Hypothetically, these septic emboli
remaining in the pulmonary circulation may be a source for future fa-
tal septic complications, despite accurate initial treatment. This aspect
is adequately addressed by the described percutaneous aspiration
procedure prior to and during the transvenous extraction procedure.
As our results show the aspiration procedure using the AngioVac
cannula (Angiodynamics, Latham, NY, USA) is highly effective and
successful (94% complete procedural success) with a low complica-
tion risk. The addition of this procedure to the transvenous lead ex-
traction facilitates a safe extraction procedure and avoids the need
for an open surgical approach especially in cases with large lead vege-
tations and a high risk for septic embolizations into the pulmonary
circulation. Additionally, avoiding the surgical trauma of a thoracot-
omy reflects a further clinical benefit for this high-risk patient cohort.
To our knowledge, this is the largest published series using this
novel percutaneous aspiration procedure in transvenous lead extrac-
tions. Early data from two of the participating institutions of this study
has been published before as initial experiences. One series com-
prised 20 patients (Burbank, California, USA) and the other experi-
ence 35 patients (Berlin, Germany).13,14 The findings of these two
separate initial experiences are consolidated by the outcome data of
this multicentre study.
It is important to mention two current restrictions in the use of
the AngioVac device. The first one is the gap between device costs
Figure 3 Result of a percutaneous aspiration procedure of vegetations using the AngioVac system.





































































and missing specific or inadequate reimbursement of the procedure.
Elimination of this gap by adjusting reimbursement and/or device
costs are highly desirable to create options for a wider clinical use.
The second restriction is missing familiarity of electrophysiologists or
cardiologists in the use of a veno-venous extracorporeal circuit.
Limitations of the study
The current study has a few limitations, which need to be outlined.
Specifically, data were collected retrospectively with a relatively small
number of patients. Moreover, the results obtained from this study
can only be viewed as hypothesis generating and should be validated
by a larger prospective randomized trial. Furthermore, the lack of
evaluating the presence or extent of septic embolism by computed
tomography scan, or ideally by FDG/PET-CT scan, pre- and post-op-
eratively is a shortcoming of the described study. Especially, this as-
pect is an important topic that needs to be investigated in future
prospective studies.
Conclusions
In summary, the presented percutaneous aspiration procedure is
highly effective and is associated with a low complication profile. The
aspiration of vegetations immediately prior to and during the lead ex-
traction procedure avoids septic embolization into the pulmonary
circulation and potentially based on this mechanism leads to a survival
benefit.
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Right internal jugular-femoral 3 (3.0%)
Mean heparin dose per patient (IU) 17 296 (3000–40 000)
Mean intraoperative ACT (s) 379.8 (172–917)
Mean extracorporeal circuit perfusion
time (min)
30.2 ± 18.3
Outcome percutaneous aspiration procedure
Complete procedural success 95 (94.0%)
Partial success 5 (5.0%)
Failure 1 (1.0%)
Major complications (device related) 3 (3.0%)
Extraction devices
No extraction tools used 38 (15.4%)
Locking stylet 158 (64.0%)
Compression coil 149 (60.3%)
Polypropylene extraction sheath 3 (1.2%)
Powered rotational extraction sheath 140 (56.7%)
Evolution RL (Cook Medical, USA) 139 (56.3%)
Tightrail (Spectranetics, USA) 1 (0.4%)
Laser sheath (Spectranetics, USA) 14 (5.7%)
Femoral/internal jugular snare 13 (5.3%)
Outcome TLE procedure
Complete procedural success (leads) 245 (99.2%)
Clinical success (leads) 247 (100%)






30-day mortality 3 (3.0%)
This gives an overview of all the results.
ACT, activated clotting time; TLE, transvenous lead extraction; TR, tricuspid
regurgitation.
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